Assessment of Morphological MRI for Pulmonary Changes in Cystic Fibrosis (CF) Patients: Comparison to Thin-section CT and Chest X-ray
Overview
Authors
Affiliations
Objectives: As pulmonary complications are life limiting in patients with cystic fibrosis (CF), repeated chest imaging [chest x-ray, computed tomography (CT)] is needed for follow up. With the continuously rising life expectancy of CF patients, magnetic resonance imaging (MRI) as a radiation-free imaging modality might become more and more attractive. The goal of this study was to prospectively assess the value of MRI for evaluation of morphologic pulmonary CF-changes in comparison to established imaging modalities.
Materials And Methods: Thirty-one CF patients (19 female, 12 male; mean age 16.7 years) with stable lung disease were examined by MRI: HASTE, coronal/transversal (TR/TE/alpha/TA: infinite/28 ms/180 degrees /18 s), multi-detector computed tomography (MDCT) (30 patients): 120 kV, dose modulated mAs, and chest x-ray (21 patients). Image evaluation: random order, 4 chest radiologists in consensus; chest x-ray: modified Chrispin-Norman score; CT and MRI: modified Helbich score. The maximal attainable score for chest x-ray was 34, for MRI and CT 25. Median scores, Pearson correlation coefficients, Bland-Altman plots, and concordance of MRI to CT on a lobar and segmental basis were calculated.
Results: The median MRI and MDCT scores were 13 (min 3, max 20) respectively 13.5 (min 0, max 20). The median chest x-ray score was 14 (min 5, max 32). Pearson correlation coefficients: MRI/CT = 0.80, P < 0.0001; MRI/chest x-ray = 0.63, P < 0.0018; chest x-ray/CT = 0.75, P < 0.0001. The median lobe related concordance was 80% for bronchiectasis, 77% for mucus plugging, 93%, for sacculation/abscesses, and 100% for collapse/consolidation.
Conclusions: Morphologic MRI of the lung in CF patients demonstrates comparable results to MDCT and chest x-ray. Because radiation exposure is an issue in CF patients, MRI might have the ability to be used as an appropriate alternative method for pulmonary imaging.
Eddy R, Parraga G Ann Am Thorac Soc. 2025; 22(1):39-40.
PMID: 40043192 PMC: 11708752. DOI: 10.1513/AnnalsATS.202411-1148ED.
Automated lung segmentation on chest MRI in children with cystic fibrosis.
Ringwald F, Wucherpfennig L, Hagen N, Mucke J, Kaletta S, Eichinger M Front Med (Lausanne). 2024; 11:1401473.
PMID: 39606627 PMC: 11600534. DOI: 10.3389/fmed.2024.1401473.
Ufuk F, Kurnaz B, Peker H, Sagtas E, Ok Z, Cobankara V Eur Radiol. 2024; .
PMID: 39592487 DOI: 10.1007/s00330-024-11216-2.
Pulmonary Vascular Dysfunctions in Cystic Fibrosis.
Amoakon J, Mylavarapu G, Amin R, Naren A Physiology (Bethesda). 2024; 39(4).
PMID: 38501963 PMC: 11368519. DOI: 10.1152/physiol.00024.2023.
MDCT and MRI in Bronchiectasis in Older Children and Young Adults - A Non-Inferiority Trial.
Lokesh , Jana M, Naranje P, Bhalla A, Kabra S, Hadda V Indian J Pediatr. 2023; 92(2):116-122.
PMID: 38051445 DOI: 10.1007/s12098-023-04921-1.